Patents by Inventor Jason O'Connell

Jason O'Connell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250246285
    Abstract: Techniques, systems and devices for glycemic control are presented. An apparatus may include a display device and a processor in electronic communication with the display device. The apparatus includes a memory communicatively connected to the processor. The memory includes instructions configuring the processor to generate a user interface through the display device and receive user input through the user interface. The processor is configured to implement an activity mode of a plurality of activity modes of a wearable medical device based on the user input. The activity mode is indicative of temporary conditions affecting blood glucose levels of the user. The processor is configured to receive biological data from a user through a biological sensor in communication with the processor and calculate an amount of medication to deliver to a user based on the biological data and the implemented activity mode.
    Type: Application
    Filed: January 23, 2025
    Publication date: July 31, 2025
    Inventors: Matthew ALLES, Joon Bok LEE, Yibin ZHENG, Jason O'CONNOR
  • Patent number: 12370307
    Abstract: In an automated insulin delivery device, fuzzy logic may be applied to the responding to the possibility of a user taking additional action that may affect the blood glucose concentration. Fuzzy sets may be defined for empirically derived different likelihoods of the user taking such additional action based on correlated factors. A membership function may be provided for each fuzzy set. The membership function may provide a probability of membership in the set based on a parameter. Each fuzzy set may have a response that is reflective of the likelihood of additional user action associated with the fuzzy set. The responses by the AID device to each of these cases may reflect the probability of each such case occurring as evidenced by empirical data.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: July 29, 2025
    Assignee: INSULET CORPORATION
    Inventors: Joon Bok Lee, Ashutosh Zade, Jason O'Connor, Yibin Zheng, Steven Cardinali
  • Patent number: 12370309
    Abstract: Exemplary embodiments may modify the cost function parameters based on current and projected mean outcomes in blood glucose level control performance. The exemplary embodiments may modify the weight coefficient R for the insulin cost so that the value of R is not fixed and is not based solely on clinical determined values. Exemplary embodiments may also adjust the cost function to address persistent low-level blood glucose level excursions for users. The exemplary embodiments may reduce the penalty of the insulin cost by the sum of the converted insulin cost of the glucose excursions above target for a period divided by a number of cycles of average insulin action time. The AID system reduces the insulin cost by the lack of insulin in previous cycles.
    Type: Grant
    Filed: March 7, 2022
    Date of Patent: July 29, 2025
    Assignee: INSULET CORPORATION
    Inventors: Joon Bok Lee, Yibin Zheng, Jason O'Connor
  • Patent number: 12343501
    Abstract: Disclosed are techniques to establish a modified pump rate that mitigates the effects of a pump occlusion and enables a recommended dosage of insulin to be output by a pump mechanism over the course of a control cycle. In an example, the pump rate may be reduced by adding a calculated time interval between application of actuation commands to extend the amount of time over which insulin may be output by the pump mechanism.
    Type: Grant
    Filed: May 12, 2023
    Date of Patent: July 1, 2025
    Assignee: INSULET CORPORATION
    Inventors: Yibin Zheng, Joon Bok Lee, Jason O'Connor
  • Publication number: 20250205427
    Abstract: Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.
    Type: Application
    Filed: March 17, 2025
    Publication date: June 26, 2025
    Inventors: Joon Bok LEE, Mengdi LI, Jason O'CONNOR, Yibin ZHENG
  • Publication number: 20250195555
    Abstract: Disclosed herein are compositions comprising an oligonucleotide that targets HGFAC. The oligonucleotide may include a small interfering RNA (siRNA) or an antisense oligonucleotide (ASO). Also provided herein are methods of treating cancer that include providing an oligonucleotide that targets HGFAC in a subject.
    Type: Application
    Filed: March 16, 2023
    Publication date: June 19, 2025
    Inventors: Omri GOTTESMAN, Andrew ALLEN, Shannon BRUSE, Brian CAJES, David JAKUBOSKY, David LEWIS, Gregory MCINNES, Jason O'ROURKE, David ROZEMA, Paul BUSKE
  • Publication number: 20250195712
    Abstract: Air purification systems and methods of use thereof are provided. The air purification system may include a housing having an intake, an outlet, and an air flow path extending therebetween. A removable rectangular housing may be positioned within the external housing, an interior of the removable rectangular housing having a reflective surface. In addition, an elongated light may be removeably disposed in removable rectangular housing, such that the elongated light may be actuated to emit light to disinfect an air flow. Accordingly, the system may receive air flow through the intake of the external housing, and direct the air flow across the air flow path through an inlet of the removable rectangular housing, out an outlet of the removable rectangular housing, and out the outlet of the air distribution duct.
    Type: Application
    Filed: December 13, 2023
    Publication date: June 19, 2025
    Applicant: One Lightwave Manufacturing
    Inventors: Derek CUTHBERTSON, Eric BLOMSTER, Jason O’CONNOR
  • Publication number: 20250198985
    Abstract: A method for separating particles in a biofluid includes pretreating the biofluid by introducing an additive, flowing the pretreated biofluid through a microfluidic separation channel, and applying acoustic energy to the microfluidic separation channel. A system for microfluidic separation, capable of separating target particles from non-target particles in a biofluid includes at least one microfluidic separation channel, a source of biofluid, a source of additive, and at least one acoustic transducer coupled to the microfluidic separation channel. A kit for microfluidic particle separation includes a microfluidic separation channel connected to an acoustic transducer, a source of an additive, and instructions for use.
    Type: Application
    Filed: March 4, 2025
    Publication date: June 19, 2025
    Inventors: Jason O. Fiering, Kenneth T. Kotz
  • Patent number: 12329928
    Abstract: A fluid delivery device comprising a fluid reservoir; a transcutaneous access tool fluidly coupled to the fluid reservoir; and a drive mechanism for driving fluid from the reservoir, the drive mechanism comprising a plunger received in the reservoir; a leadscrew extending from the plunger; a nut threadably engaged with the leadscrew; a drive wheel; and a clutch mechanism coupled to the drive wheel, wherein the clutch mechanism is configured to allow the nut to pass through when disengaged and is configured to grip the nut when engaged such that the drive wheel rotates the nut to advance the drive rod and the plunger into the reservoir.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: June 17, 2025
    Assignee: Insulet Corporation
    Inventors: Steven Diianni, Ian McLaughlin, Jason O'Connor, Robert Campbell, Kevin Schmid
  • Publication number: 20250189387
    Abstract: A system for calorimetry includes a plurality of wells disposed upon a well plate, an input feature to deposit a sample within each well, and light sources configurable to irradiate each of the wells in the well plate, and their samples, with incident light. A photonic sensor chip at a bottom of each well includes a plural nanohole array sensor on a substrate. A light detector positioned below the well is configured to measure the transmission of light through the sensors, obtaining a series of optical transmission measurements. A heater is in thermal contact with each of the wells, applying a transient thermal increase to each well, and the sample therein, at a known heat rate.
    Type: Application
    Filed: March 13, 2023
    Publication date: June 12, 2025
    Inventors: Gregory J. Kowalski, Dale N. Larson, Jason O. Fiering, Yuwei Zhang
  • Patent number: 12322914
    Abstract: A communications connector has a shielded jack body and a wire cap. The shielded jack body has a single pair of plug interface contacts having a first thickness and a single pair of insulation displacement having a second smaller thickness. The plug interface contacts are configured to electrically connect to the insulation displacement contacts. The wire cap is configured to terminate a pair of conductors to the pair of insulation displacement contacts by being secured to the shielded jack body in a direction perpendicular to a direction of an insertion of an associated connector.
    Type: Grant
    Filed: August 31, 2022
    Date of Patent: June 3, 2025
    Assignee: Panduit Corp.
    Inventors: Benjamin S. Novak, Satish I. Patel, Sean W. Lenz, Roman J. Churnovic, Robert E. Fransen, Robert L. Fritz, Jason O'Young
  • Patent number: 12300375
    Abstract: Disclosed are examples of a device, a system, methods and computer-readable medium products operable to implement functionality to determine and respond to a purpose of a meal. An algorithm or application may receive data that may include data related to a meal purpose from data sources and determine whether any of the data received from the plurality of data sources was received from a direct data source or an indirect data source. The data may be evaluated to determine a purpose of the meal. Based on the results of the evaluation, instructions may be generated to provide an appropriate response based on the determined purpose of the meal. The generated instructions to provide the appropriate response based on the determined purpose of the meal may be output.
    Type: Grant
    Filed: January 9, 2023
    Date of Patent: May 13, 2025
    Assignee: INSULET CORPORATION
    Inventors: David Nazzaro, Steven Cardinali, Nicholas Conte, Daniel Allis, Jason O'Connor, Joon Bok Lee, Ashutosh Zade, Timothy Henning, Thomas Metzmaker, Ian McLaughlin
  • Publication number: 20250144295
    Abstract: Exemplary embodiments may address the problem of missing blood glucose concentration readings from a glucose monitor that transmits blood glucose concentration readings over a wireless connection due to problems with the wireless connection. In the exemplary embodiments, an automated insulin delivery (AID) device uses an estimate in place of a missing blood glucose concentration reading in determining a predicted future blood glucose concentration reading for a user. Thus, the AID device is able to operate normally in generating insulin delivery settings despite not receiving a current blood glucose concentration reading for a current cycle. There is no need to suspend delivery of insulin to the user due to the missing blood glucose concentration reading.
    Type: Application
    Filed: January 13, 2025
    Publication date: May 8, 2025
    Inventors: Yibin ZHENG, Joon Bok LEE, Ashutosh ZADE, Jason O'CONNOR
  • Publication number: 20250132007
    Abstract: A medicament delivery system, process and techniques are provided. The medicament delivery system may include a wearable medicament delivery device, a memory storing programming instructions, and a processor. The processor may be operable to execute the programming instructions, which cause the processor to receive an available medicament delivery history of a user, and determine whether the available medicament delivery history spans an extent of time greater than a first glucose history duration. The processor, in response to a determination that the extent of time spanned by the available medicament delivery history is greater than the first glucose history duration, determines an average daily medicament delivered. The processor calculates a trust value of the available medicament delivery history, and utilizes the trust value to determine a total daily medicament value of the user.
    Type: Application
    Filed: October 8, 2024
    Publication date: April 24, 2025
    Inventors: Joon Bok LEE, Ashutosh ZADE, Yibin ZHENG, Jason O’CONNOR
  • Patent number: 12265077
    Abstract: A method for separating particles in a biofluid includes pretreating the biofluid by introducing an additive, flowing the pretreated biofluid through a microfluidic separation channel, and applying acoustic energy to the microfluidic separation channel. A system for microfluidic separation, capable of separating target particles from non-target particles in a biofluid includes at least one microfluidic separation channel, a source of biofluid, a source of additive, and at least one acoustic transducer coupled to the microfluidic separation channel. A kit for microfluidic particle separation includes a microfluidic separation channel connected to an acoustic transducer, a source of an additive, and instructions for use.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: April 1, 2025
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Jason O. Fiering, Kenneth T. Kotz
  • Patent number: 12257420
    Abstract: Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.
    Type: Grant
    Filed: February 8, 2024
    Date of Patent: March 25, 2025
    Assignee: INSULET CORPORATION
    Inventors: Joon Bok Lee, Mengdi Li, Jason O'Connor, Yibin Zheng
  • Publication number: 20250090742
    Abstract: Medical devices and related methods are described, including a medical device that includes a tubular assembly including a plurality of tubes. Each tube of the plurality of tubes may be configured to be coupled to a vacuum source to deliver negative pressure to a distal end of each respective tube of the plurality of tubes. The medical device may further include a porous assembly including a plurality of sections and may be coupled to a distal end of the tubular assembly. Each section of the plurality of sections may be coupled to a respective tube of the plurality of tubes.
    Type: Application
    Filed: September 9, 2024
    Publication date: March 20, 2025
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Anthony Frank TASSONI, JR., Martin BURKE, Jason O'CONNELL, Ryan WILBUR
  • Publication number: 20250082842
    Abstract: In an aspect, an adhesive patch is presented. The adhesive patch has a top surface configured to adhere to a wearable medical device. The adhesive patch has a bottom surface opposite the top surface, wherein the bottom surface includes an adhesive layer configured to adhere to a user's skin. The adhesive patch has a first perforation extending through the top and bottom surfaces, the first perforation configured to receive a piercing element from the wearable medical device.
    Type: Application
    Filed: September 12, 2024
    Publication date: March 13, 2025
    Inventors: John BUSSIERE, Joon Bok LEE, Yibin ZHENG, Ashutosh ZADE, Jason O’CONNOR
  • Publication number: 20250065039
    Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.
    Type: Application
    Filed: September 13, 2024
    Publication date: February 27, 2025
    Inventors: Jason O'CONNOR, Matthew ALLES, Robert SANZONE, Craig BRODEUR, Joseph MELO, Christopher WILLIAMS, Noel SCHAEFFER
  • Publication number: 20250058042
    Abstract: The exemplary embodiments may provide a correction factor (CF) for a user that is dynamically adjustable based on current glucose level. In some exemplary embodiments, the CF of the user is adjusted based on the current glucose level of the user. As the current glucose level of the user increases to be above a threshold, the CF may be adjusted to reflect a decrease in the insulin sensitivity of the user. This adjustment may cause the control system to increase the amount of insulin delivered to the user as the glucose level of the user exceeds the threshold. Similarly, the CF of the user may be adjusted based on the current target glucose level of the user or based on a combination of the current glucose level of the user and the current target glucose level of the user.
    Type: Application
    Filed: August 12, 2024
    Publication date: February 20, 2025
    Inventors: Joon Bok LEE, Yibin ZHENG, William WHITELEY, Jason O’CONNOR